Becton, Dickinson and Co. news

   Watch this stock
Showing stories 1 - 10 of about 103   

Articles published

BDX 117.17 +0.69 (0.59%)
price chart
Becton, Dickinson and Given �Underweight� Rating at JPMorgan Chase & Co ...
Becton, Dickinson and Co. logo JPMorgan Chase & Co. reiterated their underweight rating on shares of Becton, Dickinson and (NYSE:BDX) in a research note released on Friday morning.
Becton, Dickinson and Stock Rating Reaffirmed by JPMorgan Chase & Co. (BDX)  Watch List News (press release)
Becton, Dickinson: Better Bargain Than You Think (BDX)  Seeking Alpha (registration)
Related articles »  
October 18th Options Now Available For Becton, Dickinson (BDX)
Investors in Becton, Dickinson and Co. (NYSE: BDX) saw new options become available today, for the October 18th expiration.
Related articles »  
Becton, Dickinson and Given Average Rating of "Hold" by Analysts (NYSE:BDX)
Becton, Dickinson and (NYSE:BDX) opened at 118.06 on Monday. Becton, Dickinson and has a one year low of $96.73 and a one year high of $120.66.
Becton, Dickinson and Given Consensus Rating of "Hold" by Analysts (NYSE:BDX)
Becton, Dickinson and logo Shares of Becton, Dickinson and (NYSE:BDX) have earned an average rating of �Hold� from the sixteen ratings firms that are currently covering the company, Stock Ratings News reports. Two equities research analysts have rated ...
Becton, Dickinson and Given Average Recommendation of �Hold� by Analysts ...
Becton, Dickinson and logo Shares of Becton, Dickinson and (NYSE:BDX) have been given an average rating of �Hold� by the sixteen analysts that are presently covering the company, StockRatingsNetwork.com reports. Two research analysts have rated the ...
Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton ...
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis.
Related articles »  
Stocks Buzz -Becton, Dickinson and Co.(NYSE:BDX) ,Allergan, Inc.(NYSE:AGN ...
Las Vegas, NV - 28 August, 2014� (TechSonian) �Becton, Dickinson and Co.(NYSE:BDX) a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide.
News Buzz: Travelzoo Inc. (NASDAQ:TZOO), Enphase Energy (NASDAQ:ENPH ...
BD Diagnostics, a segment of leading global medical technology company Becton, Dickinson and Company (NYSE:BDX), announced the availability of the Total Nucleic Acid (TNA) suite of reagents for the BD MAX System.
Related articles »  
Investors Alert: Semtech Corporation (NASDAQ:SMTC), General Electric ...
6, BD Medical, a segment of Becton, Dickinson and Company (NYSE:BDX) a leading global medical technology company, announced the retail pharmacy launch of BD AutoShield� Duo, the only pen needle with patented dual front and back-end shields that ...
Failure Of Appellant To Appeal Damages Award Precludes District Court To ...
Becton, Dickinson, and Co., Case No. 13-1567 (Fed. Cir., July 7, 2014) (Linn, J.). Retractable Technologies sued Becton Dickinson for infringing its patents directed to medical syringes.